Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Legence Corp. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2023
FY2025
FY2025
Revenue
1,615
2,099
2,550
Cost of revenue
1,300
1,668
2,015
Gross profit
315
431
536
Selling, general and administrative
186
243
343
Operating income
10.3
70.4
61.6
Interest expense
68.2
91.6
102
Interest income
4.25
5.46
4.49
Other non-operating income
-64.2
-93.5
-117
Pre-tax income
-53.9
-23.1
-55.1
Income tax
-7.92
4.52
22.2
Net income to minority interests
0
0.91
-17.5
Net income
-46
-28.6
-59.8
EBITDA
90.5
168
162
Balance sheet
FY2023
FY2025
FY2025
Cash and equivalents
81.2
230
Receivables
449
584
Inventory
10.2
11.3
Other current assets
38.5
36.2
Total current assets
756
1,110
Property, plant and equipment
73.4
92.3
Lease right-of-use assets
90.9
117
Goodwill
676
781
764
Intangible assets
624
551
Other non-current assets
26.3
43.8
Total assets
2,353
2,679
Accounts payable
127
246
Accrued liabilities
28.5
16.5
Deferred revenue
165
164
339
Short-term debt
23
16.7
Total current liabilities
411
708
Long-term debt
1,586
812
Lease liabilities
80.7
104
Other non-current liabilities
35.9
12.1
Total liabilities
2,149
1,891
Total debt
1,609
829
Paid-in capital
702
Retained earnings
-250
-310
Other comprehensive income
9.11
-0.7
Shareholders' equity
392
Minority interests
397
Total equity
789
Total liabilities and equity
2,353
2,679
Cash flow statement
FY2023
FY2025
FY2025
Net income
-46
-27.6
-77.3
Depreciation and amortization
80.2
97.2
100
Stock-based compensation
10.1
5.41
67.6
Deferred income tax
-13.3
-13.7
15.3
Change in receivables
-81
18
-130
Cash from operations
33.9
29.3
257
Capital expenditures
-17.1
-19
-37.9
Acquisitions
-120
-225
-16.5
Cash from investing
-134
-244
-54
Cash from financing
128
207
-53.8
Net change in cash
28.5
-7.75
149
Free cash flow
16.8
10.3
219
Interest paid
61.8
85.7
96.9
Income taxes paid
10.2
17.5
16.4
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $52.52 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
18.7%
Gross profit / revenue.
Operating margin
0.8%
Operating income / revenue.
EBITDA margin
4.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-1.6%
Pre-tax income / revenue.
Net margin
-1.2%
Net income / revenue.
FCF margin
8.6%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
10.4%
Cash from operations / revenue.
Return on equity (ROE)
-7.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-1.2%
Net income / average total assets.
Return on invested capital (ROIC)
1.7%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue
12.4%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
4.3%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.8%
Capital expenditures / revenue.
D&A / revenue
3.3%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
21.5%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
24.4%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
-12.5%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
-3.3%
EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
777.7%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
2,034.0%
Free cash flow vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
13.9%
Total assets vs the same period a year earlier. Only from a positive base.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.35x
Current assets / current liabilities.
Quick ratio
0.99x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.24x
(Cash + short-term investments) / current liabilities.
Debt / equity
1.72x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
27.7%
Total debt / total assets.
Liabilities / assets
73.9%
Total liabilities / total assets.
Net debt
$742.6M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
4.85x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Days inventory + days sales outstanding - days payables.
Capex / operating cash flow
16.9%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.59
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$49.26
Revenue / diluted weighted shares.
FCF per share
$4.25
Free cash flow / diluted weighted shares.
Operating cash flow per share
$5.11
Cash from operations / diluted weighted shares.
Book value per share
$7.90
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
1.52x
Market cap / revenue.
P/B
9.45x
Market cap / shareholders' equity. Only when equity is positive.
P/FCF
17.6x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
14.6x
Market cap / cash from operations, when positive.
EV/Sales
1.71x
Enterprise value / revenue.
EV/EBIT
218x
Enterprise value / operating income, when both are positive.
EV/EBITDA
41.9x
Enterprise value / EBITDA, when both are positive.
EV/FCF
19.9x
Enterprise value / free cash flow, when both are positive.
FCF yield
5.7%
Free cash flow / market cap.
Earnings yield
-0.8%
Net income / market cap (the inverse of P/E).
What was Legence Corp.'s revenue in fiscal 2025?
Legence Corp. reported revenue of $2.55B for fiscal 2025, 21.5% higher than the year before.
Was Legence Corp. profitable in fiscal 2025?
No. It reported a net loss of $59.8M.
How much free cash flow did Legence Corp. generate in fiscal 2025?
Cash from operations of $256.9M minus capital expenditures of $37.9M left free cash flow of $218.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.